TipRanks on MSN
Dyne announces additional one-year data from ACHIEVE study
Dyne Therapeutics (DYN) last night announced additional one-year data from its ongoing Phase 1/2 ACHIEVE clinical trial of zeleciment basivarsen ...
Robust improvement demonstrated across diverse set of clinical measures -- Patient-reported outcomes support clinical meaningfulness of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results